NYSE$ATR
AptarGroup Inc. · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
AptarGroup reported solid second quarter results driven by growth of proprietary drug delivery systems and margin improvement.
AptarGroup's second quarter 2024 results showed a 2% increase in reported sales and a 3% increase in core sales. Net income increased by 9% to $90 million, with earnings per share rising by 8% to $1.34 and adjusted earnings per share increasing by 12% to $1.37. The Pharma segment delivered strong sales growth, and margins improved due to higher value product sales and cost management efforts.
- Reported sales increased 2% and core sales increased 3%.
- Reported earnings per share increased 8% to $1.34, and adjusted earnings per share increased 12% to $1.37.
- Reported net income increased 9% to $90 million, and adjusted EBITDA increased 6% to $193 million.
- Pharma segment delivered reported sales growth of 6% and core sales growth of 7% due to demand for proprietary drug delivery systems.
Headline financials
Revenue & EPS history
AptarGroup · Revenue · Quarterly
$910M
Revenue by segment
AptarGroup · $893M total across 3 segments · Q3 2023
- Pharma$389M+13.3%43.6%
- Beauty$324M-10.0%36.3%
- Closures$180M+34.6%20.1%
Forward guidance
Aptar expects growth to continue in the third quarter, driven by proprietary drug delivery systems and a progressive recovery in North America.
Tailwinds
- Growth is expected to continue in the third quarter.
- Growth for proprietary drug delivery systems is anticipated, driven by demand for nasally delivered central nervous system drugs and allergy therapies.
- Growing demand for elastomeric components used for GLP-1.
- Consumer dispensing technologies are showing pockets of strength and progressive recovery in North America.
- Focus on cost management and improved operational leverage should benefit as volumes recover.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+0.3%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.2%
Avg return
30 days after
63%
43 / 68 earnings
Positive
+9.2%
Q4 2017
Best reaction
-9.0%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | -0.8% | -6.4% | |
| Q4 2025 | +8.3% | +12.9% | +6.5% | |
| Q3 2025 | -9.0% | -7.1% | +0.3% | |
| Q1 2025 | +2.3% | +2.1% | +6.8% | |
| Q4 2024 | -8.5% | -9.4% | -2.3% | |
| Q3 2024 | +0.8% | +0.6% | +2.3% | |
| Q2 2024 | +1.7% | +1.1% | +4.4% | |
| Q1 2024 | +2.4% | +3.1% | +5.8% | |
| Q4 2023 | +5.4% | +3.1% | +8.6% | |
| Q3 2023 | +0.1% | -0.9% | +4.2% | |
| Q2 2023 | +3.2% | +2.1% | +6.3% | |
| Q1 2023 | +2.4% | +4.1% | -1.4% | |
| Q4 2022 | +5.7% | +4.2% | +0.3% | |
| Q3 2022 | +2.1% | -1.9% | +6.9% | |
| Q2 2022 | +1.6% | +0.5% | -1.5% | |
| Q1 2022 | +3.4% | +2.5% | -2.0% | |
| Q4 2021 | +3.3% | +3.8% | +2.7% | |
| Q3 2021 | -3.6% | +1.7% | +1.0% | |
| Q2 2021 | -6.3% | -6.6% | -2.3% | |
| Q1 2021 | -0.2% | +2.6% | -2.5% | |
| Q4 2020 | -7.7% | -10.4% | -2.7% | |
| Q3 2020 | +1.6% | +6.4% | +13.3% | |
| Q2 2020 | -3.0% | -0.2% | -0.6% | |
| Q1 2020 | -3.6% | -4.1% | +1.2% | |
| Q4 2019 | -2.6% | -7.0% | -19.6% | |
| Q3 2019 | -7.1% | -8.9% | -6.0% | |
| Q2 2019 | -5.0% | -5.4% | -1.3% | |
| Q1 2019 | +1.3% | +2.3% | +2.0% | |
| Q4 2018 | +1.5% | +0.0% | +2.2% | |
| Q3 2018 | +1.8% | +2.1% | +2.0% | |
| Q2 2018 | +8.6% | +8.1% | +9.6% | |
| Q1 2018 | +0.3% | +0.4% | +1.0% | |
| Q4 2017 | +9.2% | +11.8% | +9.6% | |
| Q3 2017 | -0.6% | -1.6% | -2.5% | |
| Q2 2017 | -6.5% | -6.3% | -6.4% | |
| Q1 2017 | +1.2% | +1.1% | +6.3% | |
| Q4 2016 | +1.7% | +0.4% | +4.4% | |
| Q3 2016 | -4.3% | -7.4% | -0.3% | |
| Q2 2016 | -1.9% | -3.9% | -1.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | +8.3% | — | — | |
| Q1 2015 | +2.4% | — | — | |
| Q4 2014 | +1.8% | — | — | |
| Q3 2014 | +2.0% | — | — | |
| Q2 2014 | -3.5% | — | — | |
| Q1 2014 | -0.1% | — | — | |
| Q4 2013 | +1.9% | — | — | |
| Q3 2013 | +0.2% | — | — | |
| Q2 2013 | -2.1% | — | — | |
| Q1 2013 | -2.0% | — | — | |
| Q4 2012 | -0.8% | — | — | |
| Q3 2012 | -3.5% | — | — | |
| Q2 2012 | +2.6% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q3 2011 | +5.8% | — | — | |
| Q2 2011 | -5.0% | — | — | |
| Q1 2010 | +2.2% | — | — | |
| Q1 2011 | +2.3% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2010 | +2.9% | — | — | |
| Q3 2009 | +2.9% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q2 2009 | +0.5% | — | — | |
| Q2 2010 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro